EUVIMEDEUVIMED entdecken
Crossref

A Liver Stiffness–Based Etiology-Independent Machine Learning Algorithm to Predict Hepatocellular Carcinoma

Huapeng Lin, Guanlin Li, Adèle Delamarre, Sang Hoon Ahn, Xinrong Zhang, Beom Kyung Kim, Lilian Yan Liang, Hye Won Lee, Grace Lai-Hung Wong, Pong-Chi Yuen, Henry Lik-Yuen Chan, Stephen Lam Chan und 4 weitere

Clinical Gastroenterology and Hepatology · 2024-03 · 22 (3) · 602-610.e7

DOI: 10.1016/j.cgh.2023.11.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2024-03. Verfasst von Huapeng Lin und 15 weiteren Autor:innen. Beteiligte Einrichtung: Medical Data Analytics Center, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong; State Key Laboratory of Diges…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Hepatitis B, Chronic, Hepatitis B. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Chinese University of Hong Kong, Health and Medical Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: The existing hepatocellular carcinoma (HCC) risk scores have modest accuracy, and most are specific to chronic hepatitis B infection. In this study, we developed and validated a liver stiffness-based machine learning algorithm (ML) for prediction and risk stratification of HCC in various chronic liver diseases (CLDs). METHODS: MLs were trained for prediction of HCC in 5155 adult patients with various CLDs in Korea and further tested in 2 prospective cohorts from Hong Kong (HK) (N = 2732) and Europe (N = 2384). Model performance was assessed according to Harrell's C-index and time-dependent receiver operating characteristic (ROC) curve. RESULTS: We developed the SMART-HCC score, a liver stiffness-based ML HCC risk score, with liver stiffness measurement ranked as the most important among 9 clinical features. The Harrell's C-index of the SMART-HCC score in HK and Europe validation cohorts were 0.89 (95% confidence interval, 0.85-0.92) and 0.91 (95% confidence interval, 0.87-0.95), respectively. The area under ROC curves of the SMART-HCC score for HCC in 5 years was ≥0.89 in both validation cohorts. The performance of SMART-HCC score was significantly better than existing HCC risk scores including aMAP score, Toronto HCC risk index, and 7 hepatitis B-related risk scores. Using dual cutoffs of 0.043 and 0.080, the annual HCC incidence was 0.09%-0.11% for low-risk group and 2.54%-4.64% for high-risk group in the HK and Europe validation cohorts. CONCLUSIONS: The SMART-HCC score is a useful machine learning-based tool for clinicians to stratify HCC risk in patients with CLDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHepatitis B, ChronicHepatitis BAdultHumansProspective StudiesRisk FactorsAlgorithmsMachine LearningLiver CirrhosisAntiviral Agents

Stichwörter der Autor:innen

Artificial IntelligenceCirrhosisLiver CancerLiver FibrosisTransient Elastography

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Medical Data Analytics Center, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong.
  • Hepatology Unit, Hôpital Haut Lévêque, Bordeaux University Hospital, Bordeaux, France; INSERM U1312, Bordeaux University, Bordeaux, France.
  • Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea; Yonsei Liver Center, Severance Hospital, Seoul, Korea.
  • Department of Computer Science, Hong Kong Baptist University, Hong Kong.
  • Medical Data Analytics Center, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong; Union Hospital, Hong Kong.
  • Department of Clinical Oncology, Sir YK Pao Centre for Cancer, The Chinese University of Hong Kong, Hong Kong; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong.

Förderung

  • Chinese University of Hong Kong
  • Health and Medical Research Fund

Zitieren

APA

Lin, H., Li, G., Delamarre, A., Ahn, S. H., Zhang, X., Kim, B. K., Liang, L. Y., Lee, H. W., Wong, G. L., Yuen, P. C., Chan, H. L., Chan, S. L., Wong, V. W., de Lédinghen, V., Kim, S. U., & Yip, T. C. (2024). A Liver Stiffness–Based Etiology-Independent Machine Learning Algorithm to Predict Hepatocellular Carcinoma. Clinical Gastroenterology and Hepatology, 22(3), 602-610.e7. https://doi.org/10.1016/j.cgh.2023.11.005

Vancouver

Lin H, Li G, Delamarre A, Ahn SH, Zhang X, Kim BK, et al. A Liver Stiffness–Based Etiology-Independent Machine Learning Algorithm to Predict Hepatocellular Carcinoma. Clinical Gastroenterology and Hepatology. 2024;22(3):602-610.e7. doi:10.1016/j.cgh.2023.11.005

BibTeX
@article{Lin2024,
  author = {Lin, Huapeng and Li, Guanlin and Delamarre, Adèle and Ahn, Sang Hoon and Zhang, Xinrong and Kim, Beom Kyung and Liang, Lilian Yan and Lee, Hye Won and Wong, Grace Lai-Hung and Yuen, Pong-Chi and Chan, Henry Lik-Yuen and Chan, Stephen Lam and Wong, Vincent Wai-Sun and de Lédinghen, Victor and Kim, Seung Up and Yip, Terry Cheuk-Fung},
  title = {A Liver Stiffness–Based Etiology-Independent Machine Learning Algorithm to Predict Hepatocellular Carcinoma},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2024},
  volume = {22},
  number = {3},
  pages = {602--610.e7},
  doi = {10.1016/j.cgh.2023.11.005}
}
Kostenlos starten →